You have to be signed in to use this resource.
Risk assessment in pT1 colorectal cancer – webinar - 16 May 2024
Colorectal cancer (CRC) is a common malignancy worldwide. The clinical outcome in CRC is closely related to the disease stage. Identification of CRC at an early stage i.e., pT1, is associated with a very good prognosis in many cases. However, approximately 10% of patients with these pT1 CRC will develop regional lymph node metastases (LNM) and are best treated by surgical resection of the affected bowel segment. The most widely used methods for determining LNM risk in pT1 CRC will be presented, together with a discussion of emerging and potential risk factors.
Resource details
| Contributed by: | Pathology Portal |
| Authored by: |
|
| Licence: | © All rights reserved More information on licences |
| First contributed: | 27 January 2026 |
| Audience access level: | General user |
Share this resource
Report an issue with this resource
You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.
You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.